Clinical Trial Update: Study of CellCept for Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of CellCept (mycophenolate mofetil) for advanced pancreatic cancer has completed; the snippet does not include results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Columbia University | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED